
"NHS England's upcoming PATHWAYS trial was put on hold last week after the Medicines and Healthcare products Regulatory Agency (MHRA) voiced concerns regarding its methodology. Headed by King's College London (KCL), the £10million study, which will analyse the effects of puberty suppressants on transgender adolescents, was commissioned after health secretary Wes Streeting indefinitely extended a ban on new prescriptions for the medication."
"In a letter published on 20 February, the MHRA recommended pausing the trial to discuss "potential amendments" which included expanding the withdrawal criteria for participants with certain health risks. The trial, which was the only way to access the treatment via the NHS, will now remain on hold for an indefinite period until discussions between the MHRA and researchers have concluded."
"According to a statement from the Department of Health and Social Care (DHSC) shared with PinkNews, puberty blockers are now completely inaccessible for trans youngsters. "Children with gender dysphoria will still be able to receive care through new regional Children and Young People's gender services, which provide holistic care, centred on psychosocial support.""
NHS England has temporarily halted the PATHWAYS trial, a £10 million study led by King's College London examining puberty suppressants' effects on transgender adolescents. The Medicines and Healthcare products Regulatory Agency (MHRA) paused the trial citing methodology concerns and recommending potential amendments, including expanded withdrawal criteria for participants with certain health risks. This trial was the only NHS pathway for trans youth to access puberty blockers following health secretary Wes Streeting's indefinite ban on new prescriptions. The Department of Health and Social Care states trans youth will receive alternative care through regional gender services focused on psychosocial and mental health support. The pause remains indefinite pending MHRA and researcher discussions.
#puberty-blockers #transgender-youth-healthcare #nhs-trial-pause #gender-dysphoria-treatment #medical-regulation
Read at PinkNews | Latest lesbian, gay, bi and trans news | LGBTQ+ news
Unable to calculate read time
Collection
[
|
...
]